COMMUNIQUÉS West-GlobeNewswire

WORLD RENOWNED IMMUNOLOGIST, PROFESSOR ERIC VIVIER, JOINS INNATE PHARMA AS CHIEF SCIENTIFIC OFFICER

08/01/2018 - 07:01

WORLD RENOWNED IMMUNOLOGIST, PROFESSOR ERIC VIVIER, JOINS INNATE PHARMA AS CHIEF SCIENTIFIC OFFICER Marseille, France, January 8, 2018 Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today [...]

IMMUNOLOGISTE DE RENOMMÉE MONDIALE, LE PROFESSEUR ÉRIC VIVIER EST NOMMÉ DIRECTEUR SCIENTIFIQUE D'INNATE PHARMA

08/01/2018 - 07:01

IMMUNOLOGISTE DE RENOMMÉE MONDIALE, LE PROFESSEUR ÉRIC VIVIER EST NOMMÉ DIRECTEUR SCIENTIFIQUE D'INNATE PHARMA Marseille, le 8 janvier 2018 Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 - IPH) annonce [...]

Addex Therapeutics Equity Research Report Update Issued by valuationLAB

08/01/2018 - 07:01

Report estimates a current value of ADXN of CHF 12.5 per share Geneva, Switzerland, 8 January 2018 - Addex Therapeutics (SIX: ADXN) announced today that the independent life science equity research firm, valuationLAB AG [...]

Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer

08/01/2018 - 07:01

Oslo, Norway, 8 January 2018: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that Michael Bogenstaetter [...]

ASLAN Pharmaceuticals Announces Shortened Timeline to Commercialisation for Varlitinib in China

08/01/2018 - 07:00

SINGAPORE, Jan. 08, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]

Mauricio Graber appointed new CEO of Chr. Hansen Holding A/S

08/01/2018 - 06:46

Company Announcement No. 1/2018 https://www.globenewswire.com/NewsRoom/AttachmentNg/d2eefaa4-165a-4d90-92bc-6ac719d2e9b0

Positive topline results with GLPG1972 in osteoarthritis patients

07/01/2018 - 22:01

Mechelen, Belgium; 7 January 2018, 22.00 CET - Galapagos NV (Euronext & NASDAQ: GLPG) reports positive preliminary topline results with a Phase 1b study in osteoarthritis (OA) patients in the United States. [...]

Sanofi and Alnylam enter into strategic restructuring of RNAi therapeutics rare disease alliance

07/01/2018 - 21:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Alnylam enter into strategic restructuring of RNAi therapeutics rare disease alliance Restructuring enables streamlined development and optimization of [...]

Sanofi et Alnylam procèdent à une restructuration stratégique de leur alliance portant sur le développement d'agents ARNi dans le traitement de maladies rares

07/01/2018 - 21:01

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Alnylam procèdent à une restructuration stratégique de leur alliance portant sur le développement d'agents ARNi dans le traitement de maladies [...]

Ultragenyx Announces Positive Interim Topline Results From First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency

07/01/2018 - 17:00

NOVATO, Cali., Jan. 07, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]

Nexstim enrols last patient in supplementary Phase III E-FIT trial

06/01/2018 - 10:01

Company announcement, Helsinki, 6 January 2018 at 11.00 Nexstim enrols last patient in supplementary Phase III E-FIT trial Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company [...]

Alzheimer’s Foundation of America Offers Winter Weather Safety Tips For Families Whose Loved Ones Are Dealing With Alzheimer’s

06/01/2018 - 00:30

NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- With extreme cold and winter storms bringing dangerously low temperatures, major snowfall and hazardous conditions to states across the US, the Alzheimer’s Foundation of [...]

Emerald Health Therapeutics Accelerates Expiry of 744,576 Remaining $2.60 Warrants

05/01/2018 - 23:42

VICTORIA, British Columbia, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSXV:EMH) (OTCQX:EMHTF) has elected to exercise its right to accelerate the expiry of the $2. [...]

Neuralstem to Present at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology

05/01/2018 - 23:25

GERMANTOWN, Md., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, chief science [...]

Neothetics Announces Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Merger With Evofem

05/01/2018 - 23:15

SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ: NEOT ) today announced that the Special Meeting of Stockholders held earlier today was convened and adjourned without any business being conducted [...]

ReWalk Robotics Ltd. Appoints Ori Gon as Chief Financial Officer

05/01/2018 - 22:30

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 05, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK ) today announced the Company has appointed its Corporate Controller, Ori Gon [...]

Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc.

05/01/2018 - 22:30

YARDLEY, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (NASDAQ: ALQA ) (“Alliqua or the “Company”), a regenerative technologies company committed to restoring tissue and rebuilding lives, today [...]

Akcea Initiates Phase 2b Study of AKCEA-APOCIII-LRx in Patients with Hypertriglyceridemia and Established Cardiovascular Disease

05/01/2018 - 22:15

CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]

Amedisys to Present at the 36th Annual J.P. Morgan Healthcare Conference

05/01/2018 - 19:00

BATON ROUGE, La., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), one of America's leading home health and hospice care companies, today announced that Paul B. Kusserow, President and Chief Executive [...]